Friday, March 04, 2016 3:24:14 AM
This traded at .50 cents for awhile before running to 4 dollars in the summer of 2013.
Recent CPRX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 09:23:18 PM
- Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance • GlobeNewswire Inc. • 02/25/2026 09:07:55 PM
- Catalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference • GlobeNewswire Inc. • 02/24/2026 01:03:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 10:04:15 PM
- Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026 • GlobeNewswire Inc. • 02/11/2026 01:03:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 01:03:17 PM
- Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies • GlobeNewswire Inc. • 01/08/2026 01:03:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 10:00:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 10:00:30 PM
- The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS) • GlobeNewswire Inc. • 01/05/2026 01:03:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/30/2025 10:00:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/30/2025 10:00:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/30/2025 10:00:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/30/2025 10:00:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/30/2025 10:00:15 PM
- Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 12/15/2025 01:03:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/12/2025 09:25:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2025 10:00:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2025 10:00:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2025 10:00:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2025 10:00:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2025 10:00:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2025 10:00:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2025 10:00:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/26/2025 06:54:26 PM
